Announcement on Change of General Manager

Clarification on news articles
November 26, 2019
Board of Directors Agreed Subsidiary OBI Pharma (Shanghai) Limited to Implement Partial Intellectual Property Rights of Headquarter – Rights in China
November 28, 2019
  1. Date of the board of directors’ resolution or date of occurrence of the change: Nov 28, 2019
  2. Type of personnel (chairman or general manager): General Manager
  3. Name and resume of the replaced chairman: Amy Huang
  4. Name and resume of the new chairman:Not applicable
  5. Type of the change (please enter: “resignation”, “conge”, “tenure expired” ,“position adjustment”, “dismissal”, “retirement”, “death” or “new appointment” ): Position adjustment
  6. Reason for the change: Transfer to the CEO of OBI Pharma Biomedicine Tech (Shanghai)
  7. Effective date of the new appointment: Not applicable
  8. Any other matters that need to be specified: None